Heron Therapeutics Appoints CMO
This article was originally published in Scrip
Heron Therapeutics has appointed Neil J. Clendeninn senior vice-president and chief medical officer (CMO). Clendeninn is currently a practicing physician and program director for Palliative Medicine Partners. He is also president of his own consultancy firm CANDAID, Inc and was advisor to the company before joining Heron. Previously, Clendeninn also served as senior vice-president and head of clinical affairs at Agouron Inc.